Physician profile
Moniz Dawood
NPI 1518956879
$29,056.76
in general payments reported to CMS, 2019-2025
30 companies · $3,702 in 2025
The $3,702 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,036 · 2020: $943 · 2021: $5,210 · 2022: $5,079 · 2023: $3,249 · 2024: $3,838 · 2025: $3,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,504 · Travel and Lodging: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,503.69 |
| Travel and Lodging | $1,285.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,727.96 | 2019-2025 | Triclip, Navitor, Jot Dx |
| W. L. Gore & Associates, INC. | $3,967.42 | 2019-2025 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $3,922.65 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Edwards Lifesciences Corporation | $3,832.72 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $3,669.59 | 2019-2020 | |
| Boston Scientific Corporation | $1,884.63 | 2019-2025 | Watchman Flx, Crossboss, Wolverine Coronary Cutting Balloon |
| Abiomed | $1,686.28 | 2019-2024 | Impella |
| Cvrx, INC. | $1,181.86 | 2021-2025 | Barostim Neo System |
| Philips North America LLC | $764.17 | 2022-2024 | (Bs3) Intracardiac Und, (Ao0) Igt Devices Intracardiac, (Am7) Stellarex |
| Merck Sharp & Dohme LLC | $653.39 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Shockwave Medical, INC | $602.87 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $408.12 | 2020-2024 | Indigo System |
| Biotronik INC. | $281.39 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.10 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $175.57 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $159.96 | 2022-2025 | Camzyos, Eliquis |
| Acist Medical Systems, INC. | $150.00 | 2022 | |
| Cardiovascular Systems INC. | $140.92 | 2019-2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $121.66 | 2021-2025 | |
| Medical Device Business Services, INC. | $116.80 | 2020 | |
| Merit Medical Systems INC | $110.33 | 2020 | |
| Heartflow, INC. | $50.00 | 2023 | Ffrct |
| Chiesi USA, INC. | $34.25 | 2021-2024 | Kengreal |
| Itamar Medical INC | $33.37 | 2024 | Watchpatone |
| Astrazeneca Pharmaceuticals LP | $32.31 | 2019-2024 | Andexxa |
| Pfizer INC. | $24.89 | 2024 | |
| Glaxosmithkline, LLC. | $24.03 | 2025 | Arexvy, Shingrix |
| Innovation Technologies INC | $23.85 | 2024 | Irrisept |
| Amgen INC. | $23.17 | 2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moniz Dawood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.